The most robust evidence for potential pathological role of MYC induction in mitochondrial disease comes from our studies on the CIII-deficient Bcs1lp.S78G mice, as reviewed above (Purhonen et al., 2023). Here, MYC is linked to inborn mitochondrial metabolism disorder.